RESN · Resonant Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Revenue | $2.18M | $3.16M | $524.0K | - | $653.0K | $302.0K |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| R&D | $22.93M | $19.48M | $18.85M | $14.27M | $10.04M | $6.44M |
| SG&A | $15.20M | $12.15M | $12.04M | $11.55M | $9.64M | $8.46M |
| Total Operating Expenses | $38.13M | $31.63M | $30.89M | $25.82M | $19.69M | $15.59M |
| D&A | $900.0K | $1.00M | $985.0K | $840.0K | $721.0K | $694.0K |
| Operating Income | ($35.95M) | ($28.47M) | ($30.16M) | ($25.29M) | ($19.04M) | ($15.29M) |
| Interest Expense | - | - | - | - | - | - |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | ($14.0K) | ($22.0K) |
| Net Income | ($35.97M) | ($28.41M) | ($29.93M) | ($24.82M) | ($21.65M) | ($15.25M) |
| EPS - Basic | ($0.55) | - | - | - | - | - |
| EPS - Diluted | ($0.55) | - | - | - | - | - |
Balance Sheet
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $21.21M | $24.97M | $10.69M | $4.39M | $19.52M | $5.08M |
| Accounts Receivable | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | $1.14M | $982.0K | $1.10M | $695.0K | $708.0K | $905.0K |
| Current Assets | $21.95M | $25.69M | $11.14M | $21.79M | $20.21M | $10.05M |
| Total Assets | $28.36M | $32.73M | $18.15M | $26.24M | $23.76M | $13.20M |
| Current Liabilities | $7.00M | $5.85M | $6.33M | $3.27M | $3.10M | $3.00M |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $13.11M | $7.68M | $8.39M | $3.35M | $3.11M | $3.07M |
| Stockholders' Equity | $15.26M | $25.05M | $9.76M | $22.90M | $20.65M | $10.13M |
| Retained Earnings | ($186.88M) | ($150.91M) | ($122.49M) | ($92.56M) | ($67.81M) | ($46.16M) |
Cash Flow
| Line item | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($20.10M) | ($21.64M) | ($20.71M) | ($18.13M) | ($10.66M) | ($10.66M) |
| Investing Cash Flow | ($1.96M) | ($1.59M) | $15.63M | ($18.20M) | ($2.83M) | ($2.83M) |
| Financing Cash Flow | $18.25M | $37.46M | $11.31M | $21.31M | $16.08M | $16.08M |
| CapEx | $707.0K | $705.0K | $806.0K | $1.28M | $815.0K | $400.0K |
| Free Cash Flow | ($20.81M) | ($22.34M) | ($21.51M) | ($19.42M) | ($11.47M) | ($11.06M) |
Ratios
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | - | - |
| Operating margin | -1650.8% | -900.9% | -5755.5% | - | -2915.2% | -5062.9% |
| EBITDA margin | -1609.5% | -869.2% | -5567.6% | - | -2804.7% | -4833.1% |
| Net margin | -1651.5% | -899.2% | -5711.5% | - | -3315.9% | -5048.7% |
| Free cash flow margin | -955.4% | -707.0% | -4105.3% | - | -1757.1% | -3661.9% |
| FCF / Net income | 0.58 | 0.79 | 0.72 | 0.78 | 0.53 | 0.73 |
| R&D / Revenue | 1053.0% | 616.4% | 3598.1% | - | 1538.3% | 2133.4% |
| SG&A / Revenue | 697.8% | 384.5% | 2297.7% | - | 1476.9% | 2799.7% |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -126.8% | -86.8% | -164.9% | -94.6% | -91.1% | -115.5% |
| Return on equity | -235.8% | -113.4% | -306.8% | -108.4% | -104.9% | -150.5% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 3.13 | 4.39 | 1.76 | 6.67 | 6.52 | 3.34 |
| Quick ratio | 3.13 | 4.39 | 1.76 | 6.67 | 6.52 | 3.34 |
| Cash ratio | 3.03 | 4.27 | 1.69 | 1.35 | 6.30 | 1.69 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - |
| Equity multiplier | 1.86 | 1.31 | 1.86 | 1.15 | 1.15 | 1.30 |
| Liabilities / Assets | 0.46 | 0.23 | 0.46 | 0.13 | 0.13 | 0.23 |
| Efficiency | ||||||
| Asset turnover | 0.08 | 0.10 | 0.03 | - | 0.03 | 0.02 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | -31.1% | 503.1% | - | - | 116.2% | - |
| Revenue CAGR (3y) | - | 69.1% | 20.2% | - | - | - |
| Revenue CAGR (5y) | 48.5% | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - |
| Operating income growth (YoY) | -26.3% | 5.6% | -19.2% | -32.9% | -24.5% | -57.0% |
| Net income growth (YoY) | -26.6% | 5.1% | -20.6% | -14.6% | -42.0% | -56.9% |
| EPS growth (YoY) | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | 6.9% | -3.9% | -10.8% | -69.2% | -3.8% | -41.3% |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | -39.1% | 156.8% | -57.4% | 10.9% | 103.8% | 56.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Geographic
$2.18M totalJP$1.60M · 73.4%
Other Geographic Location$291.0K · 13.4%
CN$289.0K · 13.3%
Stability scores
Altman Z′
FY 2021 · bankruptcy risk
-8.58
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2021 · 9-point quality
1/9
Weak
- ✗Net income positive
- ✗Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- -No share dilution
- -Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Semiconductors & Related Devices
Comparing Resonant Inc against the 5 most active filers in the same SIC group.